prof. dr. P.G.M. (Peter) Mol

professor of drug regulatory science

Faculty of Medical Sciences

Telephone:

E-mail:

p.g.m.mol umcg.nl

ORCID Research Portal

Publications

An Inclusive Civil Society Dialogue for Successful Implementation of the EU HTA Regulation: Call to Action to Ensure Appropriate Involvement of Stakeholders and Collaborators

Desmet, T., Julian, E., Van Dyck, W., Huys, I., Simoens, S., Giuliani, R., Toumi, M., Dierks, C., Dierks, J., Cardone, A., Houÿez, F., Pavlovic, M., Berntgen, M., Mol, P., Schiel, A., Goettsch, W., Gianfrate, F., Capri, S., Ryan, J. & Ducournau, P.& 2 others, Solà-Morales, O. & Ruof, J., 2024, In: Journal of Market Access and Health Policy. 12, 1, p. 21-34 14 p.

Research output: Contribution to journal › Article › Academic › peer-review

Comment on: “The Assessment of Patient-Reported Outcomes for the Authorisation of Medicines in Europe: A Review of European Public Assessment Reports from 2017 to 2022”

de Vries, S. T., Al-Mugoter, N. H. S., Petkoska, I., Verweij, S., Elferink, A. J. A. & Mol, P. G. M., Jan-2024, In: Applied Health Economics and Health Policy. 22, 1, p. 123-124 2 p.

Research output: Contribution to journal › Letter › Academic › peer-review

Do efficacy results obtained from randomized controlled trials translate to effectiveness data from observational studies for relapsing-remitting multiple sclerosis?

Verweij, S., Ahmed, W., Zhou, G., Mavridis, D., Nikolakopoulos, S., Elferink, A. J., Rengerink, K. O., Bijlsma, M. J., Mol, P. G. M. & Hak, E., May-2024, In: Pharmacoepidemiology and Drug Safety. 33, 5, 12 p., e5810.

Research output: Contribution to journal › Review article › peer-review

Eligibility for omecamtiv mecarbil in a realworld heart failure population: Data from the Swedish Heart Failure Registry

Lindberg, F., Øigaard, N., Metra, M., Rosano, G. M. C., Dahlström, U., Mol, P., Hage, C., Lund, L. H. & Savarese, G., 24-May-2024, In: PLoS ONE. 19, 5 , 20 p., e0303348.

Research output: Contribution to journal › Article › Academic › peer-review

Evaluating progress towards implementation of the European HTA Regulation: Insights generated from the European Access Academy's multi-stakeholder survey

Brinkhuis, F., Ruof, J., van den Ham, H., Gianfrate, F., Strammiello, V., Berntgen, M., Pavlovic, M., Mol, P., Wasem, J., Van Dyck, W., Cardone, A., Dierks, C., Schiel, A., Solà-Morales, O., Goettsch, W. & Julian, E., Nov-2024, In: Health policy and technology. 13, 5, 10 p., 100930.

Research output: Contribution to journal › Article › Academic › peer-review

Glucagon-like peptide-1 receptor agonists use and associations with outcomes in heart failure and type 2 diabetes: data from the Swedish Heart Failure and Swedish National Diabetes Registries

Wallner, M., Biber, M. E., Stolfo, D., Sinagra, G., Benson, L., Dahlström, U., Gudbjörnsdottir, S., Cosentino, F., Mol, P. G. M., Rosano, G. M. C., Butler, J., Metra, M., Lund, L. H., Ferrannini, G. & Savarese, G., 1-Jul-2024, In: European Heart Journal - Cardiovascular Pharmacotherapy. 10, 4, p. 296-306 11 p.

Research output: Contribution to journal › Article › Academic › peer-review

Monoclonal antibody biosimilars for cancer treatment

Broer, L. N., Knapen, D. G., de Groot, D.-J. A., Mol, P. G. M., Kosterink, J. G. W., de Vries, E. G. E. & Lub-de Hooge, M. N., 21-Jun-2024, In: Iscience. 27, 6, 27 p., 110115.

Research output: Contribution to journal › Review article › peer-review

Navigating the path towards successful implementation of the EU HTA Regulation: key takeaways from the 2023 Spring Convention of the European Access Academy

Brinkhuis, F., Julian, E., van den Ham, H., Gianfrate, F., Strammiello, V., Berntgen, M., Pavlovic, M., Mol, P., Wasem, J., Van Dyck, W., Cardone, A., Dierks, C., Schiel, A., Bernardini, R., Solà-Morales, O., Ruof, J. & Goettsch, W., 2-Jul-2024, In: Health Research Policy and Systems. 22, 1, 12 p., 74.

Research output: Contribution to journal › Article › Academic › peer-review

Real-World Evidence to Support EU Regulatory Decision Making: Results From a Pilot of Regulatory Use Cases

Prilla, S., Groeneveld, S., Pacurariu, A., Restrepo-Méndez, M. C., Verpillat, P., Torre, C., Gartner, C., Mol, P. G. M., Naumann-Winter, F., Breen, K. C., Gault, N., Gross-Martirosyan, L., Benchetrit, S., Aylward, B., Stoyanova-Beninska, V., O'Donovan, M., Straus, S., Kjaer, J. & Arlett, P., Nov-2024, In: Clinical Pharmacology and Therapeutics. 116, 5, p. 1188-1197 10 p.

Research output: Contribution to journal › Review article › peer-review

Sex differences in the efficacy of angiotensin receptor blockers on kidney and cardiovascular outcomes among individuals with type 2 diabetes and diabetic kidney disease: post hoc analyses of the RENAAL and IDNT trials

de Vries, S. T., Pena, M. J., Tye, S. C., Peters, S. A. E., van Raalte, D. H., Arnott, C., Voors, A. A., Mol, P. G. M., Denig, P. & Heerspink, H. J. L., 10-Dec-2024, (E-pub ahead of print) In: Diabetologia. 9 p.

Research output: Contribution to journal › Article › Academic › peer-review